S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Castellum Stock Price, News & Analysis (NYSEAMERICAN:CTM)

$0.22
-0.03 (-12.19%)
(As of 11/29/2023 ET)
Compare
Today's Range
$0.21
$0.24
50-Day Range
N/A
52-Week Range
$0.18
$1.98
Volume
228,970 shs
Average Volume
327,801 shs
Market Capitalization
$10.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CTM stock logo

About Castellum Stock (NYSEAMERICAN:CTM)

Castellum, Inc. provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, and data analytics services. It serves customers in the federal government, financial services, healthcare, and other data application sectors. Castellum, Inc. is based in Bethesda, Maryland.

CTM Stock Price History

CTM Stock News Headlines

Castellum, Inc. Announces Execution of Debt Term Sheet
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Castellum, Inc. Announces Third Quarter Financial Results
Kepler Capital Keeps Their Buy Rating on Castellum (CTM)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
CLPS Non-GAAP EPS of $0.22, revenue of $150.3M
Castellum Inc.
Castellum subsidiary bags $3M Navy contract
Kepler Capital Reaffirms Their Buy Rating on Castellum (CTM)
Castellum, Inc. Generates Record Monthly Revenue
Castellum joins Russell Microcap Index
Why Is Castellum (CTM) Stock Up 64% Today?
See More Headlines
Receive CTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Castellum and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
11/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:CTM
CIK
N/A
Fax
N/A
Employees
207
Year Founded
N/A

Profitability

Net Income
$-14,910,000.00
Pretax Margin
-50.95%

Debt

Sales & Book Value

Annual Sales
$42.19 million
Book Value
$0.29 per share

Miscellaneous

Free Float
19,776,000
Market Cap
$10.30 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Mark C. Fuller (Age 67)
    President, CEO & Director
    Comp: $428.79k
  • Mr. Jay Oscar Wright (Age 53)
    Vice Chair, General Counsel, Secretary,Treasurer & Chief Strategy Officer
    Comp: $428.32k
  • Mr. David T. Bell (Age 52)
    CFO & Treasurer
    Comp: $341.18k
  • Mr. Glen R. Ives (Age 67)
    Chief Operating Officer
    Comp: $208.87k
  • Mr. Ian Gerrard
    Head of Corporate Finance & Accounting
  • Mr. Emil Kaunitz (Age 79)
    President of SSI
  • Amanda Douglas
    Corporate Controller














CTM Stock Analysis - Frequently Asked Questions

Are investors shorting Castellum?

Castellum saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 238,700 shares, a drop of 50.9% from the October 31st total of 485,900 shares. Based on an average daily volume of 594,800 shares, the days-to-cover ratio is currently 0.4 days. Approximately 4.1% of the company's stock are sold short.
View Castellum's Short Interest
.

How were Castellum's earnings last quarter?

Castellum, Inc. (NYSEAMERICAN:CTM) released its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.05) EPS for the quarter. The business had revenue of $11.74 million for the quarter. Castellum had a negative net margin of 48.18% and a negative trailing twelve-month return on equity of 75.37%.

What guidance has Castellum issued on next quarter's earnings?

Castellum issued an update on its FY 2024 earnings guidance on Friday, October, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $50.00 million-$50.00 million, compared to the consensus revenue estimate of $57.90 million.

Who are Castellum's major shareholders?

Castellum's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Meridian Wealth Management LLC (0.47%). Insiders that own company stock include Emil Kaunitz, Jay O Wright, John Francis Campbell and Mark C Fuller.
View institutional ownership trends
.

How do I buy shares of Castellum?

Shares of CTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:CTM) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -